Keira Driansky

Keira was appointed Executive Vice President and President of North America in May 2024.

Keira joins Ipsen from AstraZeneca, where she spent 13 years leading teams across the United States, Europe and global functions. Most recently, Keira served as Country President for Belgium and Luxembourg, where she oversaw 14 launches across various therapeutic areas — leading AZ to become the fastest growing pharma company in Belgium.

Previously, she served as VP, Global Commercial Head for Tagrisso across more than 90 countries. She also spent more than five years in AZ’s U.S. Oncology business leading multiple sales and marketing teams through six launches. Keira began her career in business development across pharmaceuticals and medical devices.

Keira also has served as an active Board Member of the AstraZeneca Foundation, Alexion Belgium and Pharma.be.

She received her MBA from Harvard Business School and an MPhil in Bioscience Enterprise from the University of Cambridge. Keira also conducted breast cancer epidemiology research at the University of Oxford as a Marshall Scholar and conducted biochemistry research at Yale under a Howard Hughes Medical Fellowship. Keira graduated summa cum laude from Yale College, receiving a B.S. in Applied Mathematics with concentrations in Molecular Biochemistry & Biophysics and Economics.